SCHEMBL5307689

SCHEMBL5307689

COC(=O)Cn1c(C)c(NS(=O)(=O)c2ccc(C(F)(F)F)cc2)c2cc(Cl)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 5/20 0.46
AKR1C3 P42330 2/20 0.44
AKR1C2 P52895 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
AKR1B1 P15121 2/20 0.44
CCR9 P51686 1/20 0.43
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
EEF2K O00418 1/20 0.41
KDM1A O60341 1/20 0.41
CCR2 P41597 2/20 0.41
CTSS P25774 1/20 0.41
FLT1 P17948 1/20 0.41
FLT4 P35916 1/20 0.41
KDR P35968 1/20 0.41
HIF1A Q16665 1/20 0.40
IDH1 O75874 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5314252 0.91 PTGDR2 (0.47) PTGDR2CA12CA1CA2CA9
SCHEMBL5312598 0.90 PTGDR2 (0.55) PTGDR2AKR1C3AKR1C2AKR1B1CCR9
SCHEMBL5307807 0.89 PTGDR2 (0.50) PTGDR2AKR1C3AKR1C2CA12CA1
SCHEMBL5311262 0.88 PTGDR2 (0.47) PTGDR2CA12CA1CA2CA9
SCHEMBL5310070 0.86 CA12 (0.43) PTGDR2CA12CA1CA2CA9
SCHEMBL5312658 0.85 MAPT (0.51) PTGDR2CA12CA1CA2CA9
SCHEMBL5313784 0.85 USP2 (0.45) PTGDR2CA12CA1CA2CA9
SCHEMBL5310476 0.82 ALDH1A1 (0.46) PTGDR2AKR1C3AKR1C2CA12CA1
SCHEMBL5310742 0.80 PTGDR2 (0.60) PTGDR2AKR1B1FLT1FLT4KDR
SCHEMBL5313192 0.80 PTGDR2 (0.48) PTGDR2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007045867-A1 3 -AMINOINDOLE COMPOUNDS AS CRTH2 RECEPTOR LIGANDS ARGENTA DISCOVERY LIMITED (GB) 2007-04-26 WO disclosed